Drug Trial Radar · NCT03952299
Oxybutynin for Post-surgical Bladder Pain and Urgency
Last checked: Nov 20, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 1, 2021
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- University of California, DavisAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 16, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 8 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Conditions
- Overactive Bladder Syndrome
- Neuropathic Bladder
Interventions
Oxybutynin Transdermal PatchDrug
Transdermal patch of oxybutynin will be used instead of oral oxybutynin.
Oral OxybutyninDrug
Oral administration of oxybutynin (5mg) every 8 hours in the hospital.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Urgency ScoresTime frame: Preoperative (one week to two months) to postoperative period (six weeks).
- Pain ScoresTime frame: Preoperative (one week to two months) to postoperative period (six weeks).
- Narcotic UsageTime frame: Postoperative (six weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California Davis Medical Center (UCDMC)
Sacramento, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.